Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin L Jones

Showing results (21-30 of 393) with videos related to

Pageof 40
Sort By:
The Lancet. Oncology|February 3, 2005
Use of endomyocardial biopsy to assess anthracycline-induced cardiotoxicityRobin L Jones, David W Miles
Developmental Biology|July 9, 2013
KIT signaling regulates primordial follicle formation in the neonatal mouse ovaryRobin L Jones, Melissa E Pepling
Molecules (Basel, Switzerland)|August 26, 2014
PM00104 (Zalypsis®): a marine derived alkylating agentBradley J Petek, Robin L Jones
Future Oncology (London, England)|May 17, 2018
Quality of life and patients' expectations in soft tissue sarcomaRobin L Jones, Axel Le Cesne
Expert Opinion on Drug Safety|March 30, 2005
The development and application of imatinibRobin L Jones, Ian R Judson
Expert Review of Anticancer Therapy|October 6, 2006
Cardiac and cardiovascular toxicity of nonanthracycline anticancer drugsRobin L Jones, Michael S Ewer
Expert Opinion on Drug Safety|July 23, 2004
Efficacy and safety of trastuzumabRobin L Jones, Ian E Smith
Future Oncology (London, England)|July 23, 2015
Cardio-oncology: a special focus issue from Future OncologyRobin L Jones, Maria Teresa Sandri
Biology of Reproduction|December 28, 2012
Role of the antiapoptotic proteins BCL2 and MCL1 in the neonatal mouse ovaryRobin L Jones, Melissa E Pepling
Oncology|April 13, 2021
Current Reality of Treating Advanced Soft Tissue Sarcoma as Illustrated by Case StudiesJavier Martín Broto, Robin L Jones
Pageof 40

Showing results (21-30 of 393) with videos related to

Sort By:
Pageof 40
The Lancet. Oncology|February 3, 2005
Use of endomyocardial biopsy to assess anthracycline-induced cardiotoxicityRobin L Jones, David W Miles
Developmental Biology|July 9, 2013
KIT signaling regulates primordial follicle formation in the neonatal mouse ovaryRobin L Jones, Melissa E Pepling
Molecules (Basel, Switzerland)|August 26, 2014
PM00104 (Zalypsis®): a marine derived alkylating agentBradley J Petek, Robin L Jones
Future Oncology (London, England)|May 17, 2018
Quality of life and patients' expectations in soft tissue sarcomaRobin L Jones, Axel Le Cesne
Expert Opinion on Drug Safety|March 30, 2005
The development and application of imatinibRobin L Jones, Ian R Judson
Expert Review of Anticancer Therapy|October 6, 2006
Cardiac and cardiovascular toxicity of nonanthracycline anticancer drugsRobin L Jones, Michael S Ewer
Expert Opinion on Drug Safety|July 23, 2004
Efficacy and safety of trastuzumabRobin L Jones, Ian E Smith
Future Oncology (London, England)|July 23, 2015
Cardio-oncology: a special focus issue from Future OncologyRobin L Jones, Maria Teresa Sandri
Biology of Reproduction|December 28, 2012
Role of the antiapoptotic proteins BCL2 and MCL1 in the neonatal mouse ovaryRobin L Jones, Melissa E Pepling
Oncology|April 13, 2021
Current Reality of Treating Advanced Soft Tissue Sarcoma as Illustrated by Case StudiesJavier Martín Broto, Robin L Jones
Pageof 40